Noah Goldfarb, MD, FAAD
SESSIONS
F013 How to Approach Challenges in Hidradenitis Suppurativa Management: Strategies to Optimize Use of HS Therapies
Mar 8, 2024
•
9:00 AM - 12:00 AM
•
Room 1B
DISCLOSURES
MoonLake Immunotherapeutics – Consultant (1099 relationship)(Fees); Novartis – Investigator(Grants/Research Funding); Sonoma Biotherapeutics – Consultant (1099 relationship)(Fees); UCB – Advisory Board(Fees);